
|Articles|May 1, 2003
Patients taking digoxin may develop color blindness
Author(s)J.G. Lawrenson, PhD, Nancy Groves
London-Routine testing for color vision deficiency is not a reliable method to detect digoxin toxicity in patients taking the drug for heart failure or other cardiac problems, said J.G. Lawrenson, PhD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA grants Fast Track Designation to Complement Therapeutics’ CTx001 for geographic atrophy
2
Nanoscope secures new US patent for Multi-Characteristic Opsin (MCO) technology platform
3
Glaucoma innovation: Eight themes to watch in 2026
4
Ocugen publishes phase 1 GARDian1 gene therapy data for Stargardt disease
5












































